Richard Bendall

Richard Bendall

Auto-generated profile, based on publicly available information

Richard Bendall

Kai Ping, Goonvrea, St Agnes, TR5 0NW, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2022 in Microbiology
Verified
Journal Article
Open access
ABAbigail Bartlett
Abigail Bartlett
DPDaniel Padfield
Daniel Padfield
LLLuke Lear
Luke Lear
RBRichard Bendall
Richard Bendall
MVMichiel Vos
Michiel Vos
There exists an enormous diversity of bacteria capable of human infection, but no up-to-date, publicly accessible list is available. Combining a pragmatic definition of pathogenicity with an extensive search strategy, we report 1513 bacterial pathogens known to infect humans described pre-2021. Of these, 73 % were regarded as established (have infected at least three persons in three or more references) and 27 % as putative (fewer than three known cases). Pathogen species belong to 10 phyla and 24 classes scattered throughout the bacterial phylogeny. We show that new human pathogens are discovered at a rapid rate. Finally, we discuss how our results could be expanded to a database, which could provide a useful resource for microbiologists. Our list is freely available and archived on GitHub and Zenodo and we have provided walkthroughs to facilitate access and use.

1 February 2013 in Seminars in Liver Disease
Verified
Journal Article
Closed access
JHJ. G. Hunter
J. G. Hunter
RBR. Bendall
R. Bendall
HDHarry Dalton
Harry Dalton
A novel hepatitis virus was long suspected as the cause of outbreaks of unexplained hepatitis with high maternal mortality in Asia. An outbreak of unexplained hepatitis in a Soviet military camp in Afghanistan led one investigator to ingest a pooled fecal extract from affected service personnel. This resulted in the discovery of the hepatitis E virus (HEV) in 1983. Subsequent studies showed that HEV was endemic in large parts of the developing world. Its incidence in industrialized nations was initially attributed to travel-related exposure. For many years after the discovery of HEV, it was considered a “new” virus, and of no relevance to developed countries. This perceived wisdom has proven to be hopelessly inaccurate. Human infections with HEV are not “new,” and are of considerable global importance, including in developed countries.

1 January 2008 in Journal of Hepatology
Verified
Journal Article
Open access
HFH.J. Fellows
H.J. Fellows
WSW. Stableforth
W. Stableforth
MJM. Joseph
M. Joseph
PTP. Thurairajah
P. Thurairajah
UWU. Warshow
U. Warshow
HDHarry Dalton
Harry Dalton

1 September 2010 in Gut
Verified
Journal Article
Open access
PDF file
HDH Dalton
H Dalton
Nassim KamarNassim Kamar
Nassim Kamar
HDHarry Dalton
Harry Dalton
RBR Bendall
R Bendall
FKF Keane
F Keane
JIJacques Izopet
Jacques Izopet
Introduction HEV is an emerging infection in the developed world. It differs from HEV endemic in developing countries as it is caused by HEV genotype 3, is thought to be a porcine zoonosis, has a predilection for middle aged/elderly males, and can cause chronic infection in the immunosuppressed. Neurological symptoms associated with HEV infection have been described in both developed and developing countries. However, to date, no systematic study of the neurological sequelae of HEV has been undertaken. Aim To describe the clinical and laboratory features of the neurological complications of HEV genotype 3 infection. Method Retrospective review of 126 patients with locally acquired acute and chronic HEV genotype 3 infection from two University Hospitals: Truro (UK) and Toulouse (France). Results Neurological complications were seen in 7/126 (5.5%) of patients with HEV. The neurological complications included inflammatory polyradiculopathy (n=3), Guillain-Barré Syndrome (n=1), bilateral brachial neuritis (n=1), encephalitis (n=1), ataxia/proximal myopathy (n=1). Three cases occurred during acute HEV infection in non-immunocompromised patients and four occurred in immunocompromised patients with chronic HEV infection (three transplant patients, and one HIV-positive patient). HEV RNA was detected in the cerebrospinal fluid (CSF) of all four patients with chronic HEV infection and neurological symptoms. In one of these cases unique HEV quasispecies were documented in the CSF. In patients with acute HEV who had neurological symptoms, HEV RNA was absent in the CSF (n=2). Follow-up was up to 4 years and neurological outcomes were: complete resolution (n=3), improvement with residual neurological deficit (n=3), no improvement (n=1). Conclusion Neurological symptoms are an emerging extra-hepatic manifestation of HEV infection. The pathophysiology is not understood, but HEV may be neurotropic, as unique HEV quasispecies were isolated from the CSF of one of our cases.

1 April 2009 in Journal of Hepatology
Verified
Journal Article
Closed access
RAR.J. Ali
R.J. Ali
LFL. Farrington
L. Farrington
VEV. Ellis
V. Ellis
RBR.P. Bendall
R.P. Bendall
GCG. Courtauld
G. Courtauld
HDHarry Dalton
Harry Dalton